{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:52:19Z","timestamp":1793674339343,"version":"4.5.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008383","name":"Stichting ParkinsonFonds","doi-asserted-by":"publisher","award":["SPF 38000"],"award-info":[{"award-number":["SPF 38000"]}],"id":[{"id":"10.13039\/501100008383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008383","name":"Stichting ParkinsonFonds","doi-asserted-by":"publisher","award":["project number: 105475"],"award-info":[{"award-number":["project number: 105475"]}],"id":[{"id":"10.13039\/501100008383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Axons, crucial for impulse transmission and cellular trafficking, are thought to be primary targets of neurodegeneration in Parkinson\u2019s disease (PD) and dementia with Lewy bodies (DLB). Axonal degeneration occurs early, preceeding and exceeding neuronal loss, and contributes to the spread of pathology, yet is poorly described outside the nigrostriatal circuitry. The insula, a cortical brain hub, was recently discovered to be highly vulnerable to pathology and plays a role in cognitive deficits in PD and DLB. The aim of this study was to evaluate morphological features as well as burden of proteinopathy and axonal degeneration in the anterior insular sub-regions in PD, PD with dementia (PDD), and DLB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      \u03b1-Synuclein, phosphorylated (p-)tau, and amyloid-\u03b2 pathology load were evaluated in the anterior insular (agranular and dysgranular) subregions of post-mortem human brains (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200927). Axonal loss was evaluated using modified Bielschowsky silver staining and quantified using stereology. Cytoskeletal damage was comprehensively studied using immunofluorescent multi-labelling and 3D confocal laser-scanning microscopy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to PD and PDD, DLB showed significantly higher \u03b1-synuclein and p-tau pathology load, argyrophilic grains, and \u00a0more severe axonal loss, particularly in the anterior agranular insula. Alternatively, the dysgranular insula showed a significantly higher load of amyloid-\u03b2 pathology\u00a0and its axonal density\u00a0correlated with cognitive performance. p-Tau contributed most to axonal loss in the DLB group, was highest in the anterior agranular insula and significantly correlated with CDR global scores for dementia. Neurofilament and myelin showed degenerative changes including swellings, demyelination, and detachment of the axon-myelin unit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results highlight the selective vulnerability of the anterior  insular sub-regions to various converging pathologies, leading to impaired axonal integrity in PD, PDD and DLB, disrupting their functional properties and potentially contributing to cognitive, emotional, and autonomic deficits.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40035-022-00325-x","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T21:02:52Z","timestamp":1670360572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Axonal degeneration in the anterior insular cortex is associated with Alzheimer\u2019s co-pathology in Parkinson\u2019s disease and dementia with Lewy bodies"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9236-2479","authenticated-orcid":false,"given":"Yasmine Y.","family":"Fathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Jonkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Bol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien","family":"Timmermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allert J.","family":"Jonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke J. M.","family":"Rozemuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma D. J.","family":"van de Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"325_CR1","unstructured":"Global, regional, and national burden of Parkinson's disease, 1990\u20132016: a systematic analysis for the Global burden of disease study 2016. Lancet Neurol. 2018;17(11):939\u201353."},{"issue":"9996","key":"325_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386(9996):896\u2013912.","journal-title":"Lancet"},{"issue":"Pt 8","key":"325_CR3","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain. 2013;136(Pt 8):2419\u201331.","journal-title":"Brain"},{"issue":"6","key":"325_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"HC Cheng","year":"2010","unstructured":"Cheng HC, Ulane CM, Burke RE. Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol. 2010;67(6):715\u201325.","journal-title":"Ann Neurol"},{"issue":"6","key":"325_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S. Parkinson\u2019s disease: mechanisms and models. Neuron. 2003;39(6):889\u2013909.","journal-title":"Neuron"},{"issue":"1","key":"325_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JPD-150769","volume":"6","author":"P Tagliaferro","year":"2016","unstructured":"Tagliaferro P, Burke RE. Retrograde axonal degeneration in Parkinson disease. J Parkinsons Dis. 2016;6(1):1\u201315.","journal-title":"J Parkinsons Dis"},{"key":"325_CR7","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.nicl.2017.03.011","volume":"14","author":"SP Caminiti","year":"2017","unstructured":"Caminiti SP, Presotto L, Baroncini D, Garibotto V, Moresco RM, Gianolli L, et al. Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson\u2019s disease. NeuroImage Clin. 2017;14:734\u201340.","journal-title":"NeuroImage Clin"},{"key":"325_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.parkreldis.2018.06.025","volume":"56","author":"GW O'Keeffe","year":"2018","unstructured":"O\u2019Keeffe GW, Sullivan AM. Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2018;56:9\u201315.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"325_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5607\/en.2010.19.3.115","volume":"19","author":"KL O'Malley","year":"2010","unstructured":"O\u2019Malley KL. The role of axonopathy in Parkinson\u2019s disease. Exp Neurobiol. 2010;19(3):115\u20139.","journal-title":"Exp Neurobiol"},{"issue":"7","key":"325_CR10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1365-2990.2011.01194.x","volume":"37","author":"S Orimo","year":"2011","unstructured":"Orimo S, Uchihara T, Kanazawa T, Itoh Y, Wakabayashi K, Kakita A, et al. Unmyelinated axons are more vulnerable to degeneration than myelinated axons of the cardiac nerve in Parkinson\u2019s disease. Neuropathol Appl Neurobiol. 2011;37(7):791\u2013802.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"325_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2003.04.001","volume":"25","author":"H Braak","year":"2004","unstructured":"Braak H, Del Tredici K. Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol Aging. 2004;25(1):19\u201323.","journal-title":"Neurobiol Aging"},{"key":"325_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.nbd.2014.07.002","volume":"77","author":"JT Lamberts","year":"2015","unstructured":"Lamberts JT, Hildebrandt EN, Brundin P. Spreading of alpha-synuclein in the face of axonal transport deficits in Parkinson\u2019s disease: a speculative synthesis. Neurobiol Dis. 2015;77:276\u201383.","journal-title":"Neurobiol Dis"},{"key":"325_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.626128","volume":"15","author":"NZ Gcwensa","year":"2021","unstructured":"Gcwensa NZ, Russell DL, Cowell RM, Volpicelli-Daley LA. Molecular mechanisms underlying synaptic and axon degeneration in Parkinson\u2019s disease. Front Cell Neurosci. 2021;15: 626128.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"325_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nan.12298","volume":"42","author":"K Del Tredici","year":"2016","unstructured":"Del Tredici K, Braak H. Review: sporadic Parkinson\u2019s disease: development and distribution of \u03b1-synuclein pathology. Neuropathol Appl Neurobiol. 2016;42(1):33\u201350.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"325_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"325_CR16","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/mds.27823","volume":"34","author":"YC Wong","year":"2019","unstructured":"Wong YC, Luk K, Purtell K, Burke Nanni S, Stoessl AJ, Trudeau LE, et al. Neuronal vulnerability in Parkinson disease: should the focus be on axons and synaptic terminals? Mov Disord. 2019;34(10):1406\u201322.","journal-title":"Mov Disord"},{"issue":"20","key":"325_CR17","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1212\/WNL.0b013e3182929f62","volume":"80","author":"TR Melzer","year":"2013","unstructured":"Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, et al. White matter microstructure deteriorates across cognitive stages in Parkinson disease. Neurology. 2013;80(20):1841\u20139.","journal-title":"Neurology"},{"issue":"Suppl 1","key":"325_CR18","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.parkreldis.2017.07.023","volume":"46","author":"LV Kalia","year":"2018","unstructured":"Kalia LV. Biomarkers for cognitive dysfunction in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2018;46(Suppl 1):S19-s23.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"325_CR19","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/nan.12501","volume":"45","author":"YY Fathy","year":"2019","unstructured":"Fathy YY, Jonker AJ, Oudejans E, de Jong FJJ, van Dam AW, Rozemuller AJM, et al. Differential insular cortex subregional vulnerability to alpha-synuclein pathology in Parkinson\u2019s disease and dementia with Lewy bodies. Neuropathol Appl Neurobiol. 2019;45(3):262\u201377.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"325_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.tics.2013.09.012","volume":"17","author":"MP van den Heuvel","year":"2013","unstructured":"van den Heuvel MP, Sporns O. Network hubs in the human brain. Trends Cogn Sci. 2013;17(12):683\u201396.","journal-title":"Trends Cogn Sci"},{"issue":"1","key":"325_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/cne.902120104","volume":"212","author":"MM Mesulam","year":"1982","unstructured":"Mesulam MM, Mufson EJ. Insula of the old world monkey. III: efferent cortical output and comments on function. J Comp Neurol. 1982;212(1):38\u201352.","journal-title":"J Comp Neurol"},{"issue":"Pt 8","key":"325_CR22","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1093\/brain\/awu084","volume":"137","author":"L Christopher","year":"2014","unstructured":"Christopher L, Koshimori Y, Lang AE, Criaud M, Strafella AP. Uncovering the role of the insula in non-motor symptoms of Parkinson\u2019s disease. Brain. 2014;137(Pt 8):2143\u201354.","journal-title":"Brain"},{"issue":"1","key":"325_CR23","doi-asserted-by":"publisher","first-page":"9437","DOI":"10.1038\/s41598-017-08667-7","volume":"7","author":"D Roquet","year":"2017","unstructured":"Roquet D, Noblet V, Anthony P, Philippi N, Demuynck C, Cretin B, et al. Insular atrophy at the prodromal stage of dementia with lewy bodies: a VBM DARTEL study. Sci Rep. 2017;7(1):9437.","journal-title":"Sci Rep"},{"issue":"8","key":"325_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13195-016-0198-6","volume":"20","author":"F Blanc","year":"2016","unstructured":"Blanc F, Colloby SJ, Cretin B, de Sousa PL, Demuynck C, O\u2019Brien JT, et al. Grey matter atrophy in prodromal stage of dementia with lewy bodies and Alzheimer\u2019s disease. Alzheimers Res Ther. 2016;20(8):31.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"325_CR25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jnc.14698","volume":"150","author":"L Walker","year":"2019","unstructured":"Walker L, Stefanis L, Attems J. Clinical and neuropathological differences between Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with lewy bodies - current issues and future directions. J Neurochem. 2019;150(5):467\u201374.","journal-title":"J Neurochem"},{"issue":"1","key":"325_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88\u2013100.","journal-title":"Neurology"},{"issue":"12","key":"325_CR27","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30(12):1591\u2013601.","journal-title":"Mov Disord"},{"issue":"6","key":"325_CR28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00401-009-0523-2","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, et al. Staging\/typing of Lewy body related alpha-synuclein pathology: a study of the brainnet Europe consortium. Acta Neuropathol. 2009;117(6):635\u201352.","journal-title":"Acta Neuropathol"},{"key":"325_CR29","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Hughes","year":"1982","unstructured":"Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566\u201372.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"325_CR30","first-page":"222","volume":"25","author":"TP Naidich","year":"2004","unstructured":"Naidich TP, Kang E, Fatterpekar GM, Delman BN, Gultekin SH, Wolfe D, et al. The insula: anatomic study and MR imaging display at 15 T. AJNR Am J Neuroradiol. 2004;25(2):222\u201332.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"325_CR31","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/01.jnen.0000182983.87106.d1","volume":"64","author":"DJ Bonthius","year":"2005","unstructured":"Bonthius DJ, Solodkin A, Van Hoesen GW. Pathology of the insular cortex in Alzheimer disease depends on cortical architecture. J Neuropathol Exp Neurol. 2005;64(10):910\u201322.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"325_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(4):389\u2013404.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"325_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"325_CR34","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005072-199710000-00002","volume":"56","author":"BT Hyman","year":"1997","unstructured":"Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the national institute on aging and the reagan institute working group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol. 1997;56(10):1095\u20137.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"325_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National institute on aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol. 2012;123(1):1\u201311.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"325_CR36","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58(12):1791\u2013800.","journal-title":"Neurology"},{"issue":"6","key":"325_CR37","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128(6):755\u201366.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"325_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol. 2016;131(1):87\u2013102.","journal-title":"Acta Neuropathol"},{"key":"325_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.parkreldis.2022.05.024","volume":"100","author":"KA Jellinger","year":"2022","unstructured":"Jellinger KA. Are there morphological differences between Parkinson\u2019s disease-dementia and dementia with lewy bodies? Parkinsonism Relat Disord. 2022;100:24\u201332.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"325_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s004010000248","volume":"101","author":"S Litchfield","year":"2001","unstructured":"Litchfield S, Nagy Z. New temperature modification makes the Bielschowsky silver stain reproducible. Acta Neuropathol. 2001;101(1):17\u201321.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"325_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","volume":"114","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Del Tredici K. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson\u2019s disease. Acta Neuropathol. 2007;114(3):231\u201341.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"325_CR42","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u201382.","journal-title":"Nat Methods"},{"key":"325_CR43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1109\/JPROC.1998.659497","volume":"86","author":"CE Shannon","year":"1998","unstructured":"Shannon CE. Communication in the presence of noise. Proc IEEE. 1998;86:447\u201357.","journal-title":"Proc IEEE"},{"key":"325_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnana.2018.00049","volume":"12","author":"MJ West","year":"2018","unstructured":"West MJ. Space balls revisited: stereological estimates of length with virtual isotropic surface probes. Frontiers Neuroanat. 2018;12:49.","journal-title":"Frontiers Neuroanat"},{"issue":"3","key":"325_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0891-0618(01)00093-X","volume":"21","author":"ME Calhoun","year":"2001","unstructured":"Calhoun ME, Mouton PR. Length measurement: new developments in neurostereology and 3D imagery. J Chem Neuroanat. 2001;21(3):257\u201365.","journal-title":"J Chem Neuroanat"},{"issue":"Pt 1","key":"325_CR46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1365-2818.2002.01006.x","volume":"206","author":"PR Mouton","year":"2002","unstructured":"Mouton PR, Gokhale AM, Ward NL, West MJ. Stereological length estimation using spherical probes. J Microsc. 2002;206(Pt 1):54\u201364.","journal-title":"J Microsc"},{"issue":"4","key":"325_CR47","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/WNP.0000000000000377","volume":"34","author":"LQ Uddin","year":"2017","unstructured":"Uddin LQ, Nomi JS, H\u00e9bert-Seropian B, Ghaziri J, Boucher O. Structure and function of the human insula. J Clin Neurophysiol. 2017;34(4):300\u20136.","journal-title":"J Clin Neurophysiol"},{"key":"325_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102364","volume":"28","author":"YY Fathy","year":"2020","unstructured":"Fathy YY, Hepp DH, de Jong FJ, Geurts JJG, Foncke EMJ, Berendse HW, et al. Anterior insular network disconnection and cognitive impairment in Parkinson\u2019s disease. Neuroimage Clin. 2020;28: 102364.","journal-title":"Neuroimage Clin"},{"issue":"1","key":"325_CR49","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/cercor\/bhr104","volume":"22","author":"DS Gallay","year":"2012","unstructured":"Gallay DS, Gallay MN, Jeanmonod D, Rouiller EM, Morel A. The insula of reil revisited: multiarchitectonic organization in macaque monkeys. Cereb Cortex. 2012;22(1):175\u201390.","journal-title":"Cereb Cortex"},{"issue":"3","key":"325_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058596","volume":"8","author":"JM Posimo","year":"2013","unstructured":"Posimo JM, Titler AM, Choi HJ, Unnithan AS, Leak RK. Neocortex and allocortex respond differentially to cellular stress in vitro and aging in vivo. PLoS One. 2013;8(3):e58596.","journal-title":"PLoS ONE"},{"issue":"1","key":"325_CR51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neurobiolaging.2003.03.001","volume":"25","author":"G Bartzokis","year":"2004","unstructured":"Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer\u2019s disease. Neurobiol Aging. 2004;25(1):5\u201318.","journal-title":"Neurobiol Aging"},{"key":"325_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1750-1326-9-43","volume":"9","author":"S Moussaud","year":"2014","unstructured":"Moussaud S, Jones DR, Moussaud-Lamodiere EL, Delenclos M, Ross OA, McLean PJ. Alpha-synuclein and tau: teammates in neurodegeneration? Mol Neurodegener. 2014;9:43.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"325_CR53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/2047-9158-1-24","volume":"1","author":"Y Duan","year":"2012","unstructured":"Duan Y, Dong S, Gu F, Hu Y, Zhao Z. Advances in the pathogenesis of Alzheimer\u2019s disease: focusing on tau-mediated neurodegeneration. Transl Neurodegener. 2012;1(1):24.","journal-title":"Transl Neurodegener"},{"issue":"12","key":"325_CR54","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","volume":"19","author":"MG Iadanza","year":"2018","unstructured":"Iadanza MG, Jackson MP, Hewitt EW, Ranson NA, Radford SE. A new era for understanding amyloid structures and disease. Nat Rev Mol Cell Biol. 2018;19(12):755\u201373.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"Pt 2","key":"325_CR55","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/brain\/awn312","volume":"132","author":"R Adalbert","year":"2009","unstructured":"Adalbert R, Nogradi A, Babetto E, Janeckova L, Walker SA, Kerschensteiner M, et al. Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain. 2009;132(Pt 2):402\u201316.","journal-title":"Brain"},{"issue":"5","key":"325_CR56","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.tins.2019.03.003","volume":"42","author":"FA Edwards","year":"2019","unstructured":"Edwards FA. A unifying hypothesis for Alzheimer\u2019s disease: from plaques to neurodegeneration. Trends Neurosci. 2019;42(5):310\u201322.","journal-title":"Trends Neurosci"},{"key":"325_CR57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neulet.2018.03.025","volume":"697","author":"AKH Stavoe","year":"2019","unstructured":"Stavoe AKH, Holzbaur ELF. Axonal autophagy: mini-review for autophagy in the CNS. Neurosci Lett. 2019;697:17\u201323.","journal-title":"Neurosci Lett"},{"issue":"13","key":"325_CR58","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1007\/s00018-018-2812-1","volume":"75","author":"Y Wang","year":"2018","unstructured":"Wang Y, Song M, Song F. Neuronal autophagy and axon degeneration. Cell Mol Life Sci. 2018;75(13):2389\u2013406.","journal-title":"Cell Mol Life Sci"},{"key":"325_CR59","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fnins.2018.00467","volume":"12","author":"RM Stassart","year":"2018","unstructured":"Stassart RM, Mobius W, Nave KA, Edgar JM. The axon-myelin unit in development and degenerative disease. Front Neurosci. 2018;12:467.","journal-title":"Front Neurosci"},{"issue":"2","key":"325_CR60","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1091\/mbc.E14-06-1049","volume":"26","author":"ED Niederst","year":"2015","unstructured":"Niederst ED, Reyna SM, Goldstein LS. Axonal amyloid precursor protein and its fragments undergo somatodendritic endocytosis and processing. Mol Biol Cell. 2015;26(2):205\u201317.","journal-title":"Mol Biol Cell"},{"issue":"7","key":"325_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109134","volume":"35","author":"R Bhattacharyya","year":"2021","unstructured":"Bhattacharyya R, Black SE, Lotlikar MS, Fenn RH, Jorfi M, Kovacs DM, et al. Axonal generation of amyloid-\u03b2 from palmitoylated APP in mitochondria-associated endoplasmic reticulum membranes. Cell Rep. 2021;35(7): 109134.","journal-title":"Cell Rep"},{"issue":"1","key":"325_CR62","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, et al. Dementia with lewy bodies: an update and outlook. Mol Neurodegener. 2019;14(1):5.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"325_CR63","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/bpa.12182","volume":"25","author":"DR Howlett","year":"2015","unstructured":"Howlett DR, Whitfield D, Johnson M, Attems J, O\u2019Brien JT, Aarsland D, et al. Regional multiple pathology scores are associated with cognitive decline in lewy body dementias. Brain Pathol. 2015;25(4):401\u20138.","journal-title":"Brain Pathol"},{"issue":"1","key":"325_CR64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, et al. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol. 2017;16(1):55\u201365.","journal-title":"Lancet Neurol"},{"key":"325_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.581767","volume":"12","author":"N Salvadores","year":"2020","unstructured":"Salvadores N, Ger\u00f3nimo-Olvera C, Court FA. Axonal degeneration in AD: the contribution of A\u03b2 and tau. Front Aging Neurosci. 2020;12: 581767.","journal-title":"Front Aging Neurosci"},{"issue":"37","key":"325_CR66","doi-asserted-by":"publisher","first-page":"9647","DOI":"10.1523\/JNEUROSCI.1899-16.2016","volume":"36","author":"MA Sherman","year":"2016","unstructured":"Sherman MA, LaCroix M, Amar F, Larson ME, Forster C, Aguzzi A, et al. Soluble conformers of A\u03b2 and tau alter selective proteins governing axonal transport. J Neurosci. 2016;36(37):9647\u201358.","journal-title":"J Neurosci"},{"issue":"4","key":"325_CR67","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS. Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014;71(4):505\u20138.","journal-title":"JAMA Neurol"},{"key":"325_CR68","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0072-9752(07)01251-1","volume":"89","author":"M Tolnay","year":"2008","unstructured":"Tolnay M, Probst A. Argyrophilic grain disease. Handb Clin Neurol. 2008;89:553\u201363.","journal-title":"Handb Clin Neurol"},{"issue":"17","key":"325_CR69","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94(17):743\u201355.","journal-title":"Neurology"},{"issue":"1","key":"325_CR70","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-019-0318-4","volume":"14","author":"A Didonna","year":"2019","unstructured":"Didonna A, Opal P. The role of neurofilament aggregation in neurodegeneration: lessons from rare inherited neurological disorders. Mol Neurodegen. 2019;14(1):19.","journal-title":"Mol Neurodegen"},{"issue":"7","key":"325_CR71","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian SH, Lewis AJ, Genoud C, Hench J, Moors TE, Navarro PP, et al. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat Neurosci. 2019;22(7):1099\u2013109.","journal-title":"Nat Neurosci"},{"issue":"3","key":"325_CR72","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00401-021-02329-9","volume":"142","author":"TE Moors","year":"2021","unstructured":"Moors TE, Maat CA, Niedieker D, Mona D, Petersen D, Timmermans-Huisman E, et al. The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson\u2019s disease brain as revealed by multicolor STED microscopy. Acta Neuropathol. 2021;142(3):423\u201348.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"325_CR73","doi-asserted-by":"publisher","first-page":"17368","DOI":"10.1038\/s41598-018-35766-w","volume":"8","author":"YS Lin","year":"2018","unstructured":"Lin YS, Lee WJ, Wang SJ, Fuh JL. Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease. Sci Rep. 2018;8(1):17368.","journal-title":"Sci Rep"},{"issue":"2","key":"325_CR74","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","volume":"25","author":"O Preische","year":"2019","unstructured":"Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease. Nat Med. 2019;25(2):277\u201383.","journal-title":"Nat Med"},{"issue":"10","key":"325_CR75","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14(10):577\u201389.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"325_CR76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1101\/cshperspect.a018309","volume":"9","author":"A Yuan","year":"2017","unstructured":"Yuan A, Rao MV. Neurofilaments and neurofilament proteins in health and disease. Cold Spring Harb Perspect Biol. 2017;9(4):3.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"325_CR77","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/ana.26014","volume":"89","author":"A Luchicchi","year":"2021","unstructured":"Luchicchi A, Hart B, Frigerio I, van Dam AM, Perna L, Offerhaus HL, et al. Axon-myelin unit blistering as early event in ms normal appearing white matter. Ann Neurol. 2021;89(4):711\u201325.","journal-title":"Ann Neurol"},{"issue":"236","key":"325_CR78","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neuroscience.2012.12.076","volume":"16","author":"A Morel","year":"2013","unstructured":"Morel A, Gallay MN, Baechler A, Wyss M, Gallay DS. The human insula: architectonic organization and postmortem MRI registration. Neuroscience. 2013;16(236):117\u201335.","journal-title":"Neuroscience"},{"key":"325_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.570019","volume":"14","author":"HT Tran","year":"2020","unstructured":"Tran HT, Tsai EHR, Lewis AJ, Moors T, Bol J, Rostami I, et al. Alterations in sub-axonal architecture between normal aging and Parkinson\u2019s diseased human brains using label-free cryogenic X-ray nanotomography. Front Neurosci. 2020;14: 570019.","journal-title":"Front Neurosci"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-022-00325-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-022-00325-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-022-00325-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:07:01Z","timestamp":1670364421000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-022-00325-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1186\/s40035-022-00325-x","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"assertion":[{"value":"17 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Postmortem human brain tissues from clinically diagnosed and neuropathologically verified donors with advanced PD were collected by the Netherlands Brain Bank (brainbank.nl). In compliance with all local ethical and legal guidelines, informed consent for brain autopsy and the use of brain tissue and clinical information for scientific research was given by either the donor or the next-of-kin. A reference to the published Code of Conduct for brain banking of BrainNet Europe (where NBB participated in) is provided in the text. The procedures of the NBB (Amsterdam, The Netherlands) were approved by the Institutional Review Board and Medical Ethical Board (METC) from the VU University Medical Center (VUmc), Amsterdam.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Wilma van de Berg was financially supported in period 2019\u20132021 by grants from Amsterdam Neuroscience, Dutch Research council (ZonMW 70\u201373305-98\u2013106; 70\u201373305-98\u2013102; 40\u201346000-98\u2013101), Stichting Parkinson Fonds (Insula 2014), MJ Fox foundation (17253) and Parkinson Association (2020-G01). Dr. Wilma van de Berg performed contract research and consultancy for Hoffmann-La Roche, Roche Tissue Diagnostics, Crossbeta Sciences and received research consumables from Hoffmann-La Roche and Prothena. All authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}